Craig Gracey Sells 2,083 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $18.00, for a total transaction of $37,494.00. Following the completion of the sale, the chief accounting officer directly owned 7,108 shares of the company’s stock, valued at approximately $127,944. This trade represents a 22.66% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Craig Gracey also recently made the following trade(s):

• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Performance

Omada Health stock opened at $18.90 on Friday. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92. The company has a market capitalization of $1.12 billion and a P/E ratio of -70.00. The stock has a 50-day simple moving average of $16.35 and a 200-day simple moving average of $14.80.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million for the quarter. As a group, analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Perceptive Advisors LLC acquired a new stake in Omada Health in the second quarter valued at about $44,402,000. Millennium Management LLC increased its position in Omada Health by 1,195.0% during the 4th quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the period. Loomis Sayles & Co. L P raised its stake in shares of Omada Health by 23.0% during the 4th quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock worth $29,283,000 after buying an additional 346,588 shares in the last quarter. Divisadero Street Capital Management LP purchased a new position in shares of Omada Health during the 3rd quarter worth approximately $30,510,000. Finally, Jefferies Financial Group Inc. acquired a new stake in shares of Omada Health in the 4th quarter valued at approximately $16,948,000.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Needham & Company LLC reissued a “buy” rating and set a $28.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Barclays increased their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday, May 8th. BMO Capital Markets dropped their price target on Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, Wells Fargo & Company increased their price objective on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.